These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group. Aldridge KE Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038 [TBL] [Abstract][Full Text] [Related]
12. Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes. Appelbaum PC; Jacobs MR; Spangler SK; Yamabe S Antimicrob Agents Chemother; 1986 Nov; 30(5):789-91. PubMed ID: 3026241 [TBL] [Abstract][Full Text] [Related]
13. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae. Simonet M; Moittie D; Philippon A; Descamps P; Veron M J Antimicrob Chemother; 1989 May; 23(5):798-800. PubMed ID: 2547748 [No Abstract] [Full Text] [Related]
14. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections. Nomura S; Hanaki H; Nagayama A J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745 [TBL] [Abstract][Full Text] [Related]
15. Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species. Fass RJ Antimicrob Agents Chemother; 1981 Feb; 19(2):361-3. PubMed ID: 6289732 [TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors. Neu HC; Fu KP Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria. Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257 [TBL] [Abstract][Full Text] [Related]
18. Implications of beta-lactamase-inhibitor combinations. Fuchs PC; Barry AL J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514 [TBL] [Abstract][Full Text] [Related]
19. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases. Philippon A; Riou JY; Guibourdenche M; Sotolongo F Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547 [TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam. Neu HC Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]